Diversified Consumer Services
Company Overview of Columbia University Medical Center
Columbia University Medical Center is an Educational Institution.
630 West 168th Street
New York, NY
Founded in 1928
Key Executives for Columbia University Medical Center
Columbia University Medical Center does not have any Key Executives recorded.
Columbia University Medical Center Key Developments
Columbia University Medical Center Announces Executive Changes
Jun 30 15
Columbia University Medical Center announced that Dr. Kevin Roth is named as chair of pathology and cell biology and pathologist-in-chief. Dr. Roth succeeds Michael Shelanski following Dr. Shelanski's 28 highly successful years as chair of the department. Dr. Shelanski, who announced his intention earlier this year to step down as chairman, will remain at Columbia as the Henry Taub Professor of Alzheimer's Disease Research and co-director of the Taub Institute on Research on Alzheimer's Disease and the Aging Brain. Dr. Roth is currently chair of the Department of Pathology at the University of Alabama at Birmingham. His research focuses on neuronal cell death regulation and neuropathology, including attempts to define the molecular pathways regulating apoptotic and nonapoptotic neuronal cell death and neuron loss in Alzheimer's disease and Parkinson's disease. Dr. Roth serves as president of the American Society for Investigative Pathology, chair of the Neural Oxidative Metabolism and Death (NOMD) Study Section.
Biogen Idec Inc. and Columbia University Medical Center to Conduct Collaborative Genetics Research
Jan 9 15
Biogen Idec Inc. and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches. The agreement will integrate genomics research conducted at Columbia with Biogen Idec’s understanding of disease mechanisms and pathways, and expertise in discovering new medicines. The collaboration will enable Biogen Idec and Columbia to investigate the genomes of patients showing unusual treatment responses or unique disease presentations and to explore the connections among genes, pathways, and disease processes. The ultimate goal will be to provide multiple qualified targets for new therapeutic approaches, increasing the potential for the development of new treatments.
Columbia University Medical Center Appoints Tom Maniatis as Director of Precision Medicine Initiative
Nov 3 14
Tom Maniatis, PhD, has been appointed director of Columbia's university-wide precision medicine initiative. He is the Isidore S. Edelman Professor of Biochemistry and chair of the Department of Biochemistry and Molecular Biophysics at Columbia University Medical Center and a cofounder of the New York Genome Center, of which Columbia is a partner.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries